ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -5 مورد

Therapeutic monoclonal antibody nomenclature

Therapeutic monoclonal antibody nomenclature
Prefix Target substem
(also called Infix)*
Source substem
(omitted in mAbs named after 2017)
SuffixΔ
Substem Definition Substem Definition
Random and distinctive -ami Serum amyloid protein (SAP)/amyloidosis -a Rat All products named before 2022:
  • -mab

Products named from 2022 onward use one of the following:

  • -tug (unmodified immunoglobulin)
  • -bart (engineered constant region)
  • -mig (bispecific or multi-specific)
  • -ment (variable region fragment)
-ba Bacterial -axo Rat-mouse
-ci Cardiovascular -e Hamster
-eni Enzyme inhibition -i Primate
-fung Fungal -o Mouse
-gro Skeletal muscle mass related growth factors and receptors -u Human
-ki Cytokine and cytokine receptors -xi Chimeric
-ler Allergen -xizu Chimeric-humanized
-ne Neural -zu Humanized
-os Bone    
-pru Immunosuppressive    
-sto Immunostimulatory    
-toxa Toxin    
-ta Tumor    
-vet Veterinary use    
-vi Viral    
Refer to general information included within UpToDate about therapeutic mAbs and specific dosing for individual products.

mAb: monoclonal antibody.

* The final letter could be omitted if it interfered with pronunciation.

¶ Non-human species are no longer used due to high immunogenicity.

Δ Changes to the suffix were made in 2022 to reduce sound-alikes and to specify the immunoglobulin structure.
Graphic 114279 Version 3.0